Document is current
Any future updates will be listed below
-
Authors
Renn, Dominik
McPartlan, Justine S.
Banala, Srinivas
Kiessling, Fabian
Talukder, Poulami
Mandl, Christian W.
Eppinger, Jörg
Chahal, Jasdave S.
Rueping, Magnus
-
Funding
Funding for this research was provided by:
King Abdullah University of Science and Technology (OSR-NTGC-2021-4587)
- License Information
-
More Information
Article History
Received: 21 November 2025
Accepted: 12 March 2026
First Online: 23 March 2026
Competing interests
: P.T., J.S.M., C.W.M., and J.S.C. are employees of Tiba Biotech LLC and have equity interests. Tiba Biotech has filed a patent on the MDNP RNA delivery system (patent application PCT/US21/25542), naming P.T. and J.S.C. as inventors. J.S.C. is also an inventor on U.S. Patent no. 10,548,959 entitled “Compositions and Methods for Modified Dendrimer Nanoparticle Delivery.” C.W.M. has worked as a freelance consultant advising commercial and nonprofit organizations working in the fields of vaccines and viral vectors. All other authors declare that they have no competing interests.
